Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 12,428 | 9,066 | 11,291 | 9,648 | 9,561 |
| Operating Income | -12,428 | -9,066 | -11,291 | -9,648 | -9,561 |
| Interest Expense | 1,725 | 1,494 | 1,269 | 1,052 | 847 |
| Other Income | 2,186 | -660 | 189 | -789 | 411 |
| Pre-tax Income | -11,967 | -11,220 | -12,371 | -11,489 | -9,997 |
| Net Income Continuous | -11,967 | -11,220 | -12,371 | -11,489 | -9,997 |
| Net Income | $-11,967 | $-11,220 | $-12,371 | $-11,489 | $-9,997 |
| EPS Basic Total Ops | -0.19 | -0.18 | -0.20 | -0.19 | -0.16 |
| EPS Basic Continuous Ops | -0.19 | -0.18 | -0.20 | -0.19 | -0.16 |
| EPS Diluted Total Ops | -0.19 | -0.18 | -0.20 | -0.19 | -0.16 |
| EPS Diluted Continuous Ops | -0.19 | -0.18 | -0.20 | -0.19 | -0.16 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.18 | -0.20 | -0.19 | N/A |
| EBITDA(a) | $-12,418 | $-9,057 | $-11,282 | $-9,639 | $-9,552 |